Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer
The Laryngoscope · 2026-06 · 136 (6) · 2621-2630
DOI: 10.1002/lary.70452 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Laryngoscope, online erschienen am 05.03.2026. Verfasst von Valentina Montanez-Azcarate und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Paranasal Sinus Neoplasms. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Objective
Although current NCCN guidelines do not recommend surgical resection for T4b sinonasal tumors, recent studies report that up to 80% of patients undergo surgery as part of their treatment. This discrepancy between guideline‐based recommendations and real‐world clinical practice led us to investigate the clinical, demographic, and institutional factors associated with undergoing surgery among patients with clinically staged T4b sinonasal cancer.
Methods
We analyzed data from the National Cancer Database (2004–2022) to identify patients diagnosed with clinical T4b sinonasal malignancies. Patients were grouped by treatment approach: surgery with adjuvant therapy vs. definitive chemoradiation. Multivariable logistic regression assessed clinical, demographic, and institutional predictors of surgery.
Results
Of 2244 patients, 57.5% received surgery as part of treatment. Surgical management was more likely among patients with private insurance (aOR 1.56, 95% CI 1.17–2.08), those treated in the Northeast (aOR 1.55, 95% CI 1.12–2.16), and patients traveling more than 100 miles for care (aOR 1.89, 95% CI 1.35–2.63). Histologic subtypes such as melanoma (aOR 13.37), neuroectodermal tumors (aOR 11.79), adenoid cystic carcinoma (aOR 2.98), and adenocarcinoma (aOR 2.99) were more likely to receive surgery. Node positivity was negatively associated with surgery (aOR 0.49).
Conclusion
Despite guideline recommendations, surgery remains common for T4b sinonasal cancer. Surgical selection appears driven by tumor biology as well as access‐ and system‐level factors. These findings highlight the evolving and context‐dependent definition of unresectability in clinical practice. Level of Evidence 3.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
- Division of Otolaryngology, Department of Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
- Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Valentina Montanez-Azcarate, Felipe Porto-Gutierrez, Brett Campbell, Alexa Kacin
Zitieren
APA
Montanez-Azcarate, V., Syed, Z., Porto-Gutierrez, F., Campbell, B., Kacin, A., Gomez, E., & Jalisi, S. (2026). Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer. The Laryngoscope, 136(6), 2621-2630. https://doi.org/10.1002/lary.70452
Vancouver
Montanez-Azcarate V, Syed Z, Porto-Gutierrez F, Campbell B, Kacin A, Gomez E, et al. Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer. The Laryngoscope. 2026;136(6):2621-2630. doi:10.1002/lary.70452
BibTeX
@article{MontanezAzcarate2026,
author = {Montanez-Azcarate, Valentina and Syed, Zoha and Porto-Gutierrez, Felipe and Campbell, Brett and Kacin, Alexa and Gomez, Ernest and Jalisi, Scharukh},
title = {Factors Influencing Surgical Management of Patients With T4b Sinonasal Cancer},
journal = {The Laryngoscope},
year = {2026},
volume = {136},
number = {6},
pages = {2621--2630},
doi = {10.1002/lary.70452}
}
EUVIMED